BioNexus Gene Lab Corp. (BGLC)
4.15
+0.01
(+0.24%)
USD |
NASDAQ |
Dec 16, 16:00
4.13
-0.02
(-0.48%)
After-Hours: 17:09
BioNexus Gene Lab EPS Diluted (Quarterly): -0.3946 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Balchem Corp. | 1.236 |
| Innospec, Inc. | 0.5179 |
| Alto Ingredients, Inc. | 0.1857 |
| WD-40 Co. | 1.563 |
| General Enterprise Ventures, Inc. | -0.5864 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.709M |
| Revenue (Quarterly) | 2.544M |
| Total Expenses (Quarterly) | 3.253M |
| Enterprise Value | 4.727M |
| Gross Profit Margin (Quarterly) | 14.85% |
| Profit Margin (Quarterly) | -27.87% |
| Earnings Yield | -30.80% |
| Normalized Earnings Yield | -30.60 |